132 related articles for article (PubMed ID: 36790004)
21. Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer.
Guo C; Wu L; Zheng X; Zhao L; Hou X; Wang Z; Han C
Curr Top Med Chem; 2023; 23(21):2048-2074. PubMed ID: 37438905
[TBL] [Abstract][Full Text] [Related]
22. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery.
Wang Y; Hu W; Yuan Y
J Med Chem; 2018 Nov; 61(21):9429-9441. PubMed ID: 29870258
[TBL] [Abstract][Full Text] [Related]
23. Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors.
Lin H; Luengo JI
Bioorg Med Chem Lett; 2019 Jun; 29(11):1264-1269. PubMed ID: 30956011
[TBL] [Abstract][Full Text] [Related]
24. In silico analysis of marine natural product for protein arginine methyltransferase 5(PRMT5) inhibitors based on pharmacophore and molecular docking.
Luo L; Tan H; Liao Y
J Biomol Struct Dyn; 2023; 41(22):13180-13197. PubMed ID: 36856049
[TBL] [Abstract][Full Text] [Related]
25. Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors.
Chen T; Sorna V; Choi S; Call L; Bearss J; Carpenter K; Warner SL; Sharma S; Bearss DJ; Vankayalapati H
Bioorg Med Chem Lett; 2017 Dec; 27(24):5473-5480. PubMed ID: 29150397
[TBL] [Abstract][Full Text] [Related]
26. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
[TBL] [Abstract][Full Text] [Related]
27. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
[TBL] [Abstract][Full Text] [Related]
28. The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.
Quiroz RV; Reutershan MH; Schneider SE; Sloman D; Lacey BM; Swalm BM; Yeung CS; Gibeau C; Spellman DS; Rankic DA; Chen D; Witter D; Linn D; Munsell E; Feng G; Xu H; Hughes JME; Lim J; Saurí J; Geddes K; Wan M; Mansueto MS; Follmer NE; Fier PS; Siliphaivanh P; Daublain P; Palte RL; Hayes RP; Lee S; Kawamura S; Silverman S; Sanyal S; Henderson TJ; Ye Y; Gao Y; Nicholson B; Machacek MR
J Med Chem; 2021 Apr; 64(7):3911-3939. PubMed ID: 33755451
[TBL] [Abstract][Full Text] [Related]
29. Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.
Chen Y; Wang Z; Zhang J; Shi Q; Yang H; Deng Y; Wang X; Liu T; Geng M; Xiong B; Huang X
Eur J Med Chem; 2024 Mar; 267():116171. PubMed ID: 38301329
[TBL] [Abstract][Full Text] [Related]
30. Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.
Asberry AM; Cai X; Deng X; Santiago U; Liu S; Sims HS; Liang W; Xu X; Wan J; Jiang W; Camacho CJ; Dai M; Hu CD
J Med Chem; 2022 Oct; 65(20):13793-13812. PubMed ID: 36206451
[TBL] [Abstract][Full Text] [Related]
31. The Discovery of Selective Protein Arginine Methyltransferase 5 Inhibitors in the Management of β-Thalassemia through Computational Methods.
Pokharel B; Ravikumar Y; Rathinavel L; Chewonarin T; Pongpom M; Tipsuwan W; Koonyosying P; Srichairatanakool S
Molecules; 2024 Jun; 29(11):. PubMed ID: 38893537
[TBL] [Abstract][Full Text] [Related]
32. Discovery of tetrahydroisoquinolineindole derivatives as first dual PRMT5 inhibitors/hnRNP E1 upregulators: Design, synthesis and biological evaluation.
Chu WH; Yang N; Zhang JH; Li Y; Song JL; Deng ZP; Meng N; Zhang J; Zhu KK; Jiang CS
Eur J Med Chem; 2023 Oct; 258():115625. PubMed ID: 37429083
[TBL] [Abstract][Full Text] [Related]
33. Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers.
Prabhu L; Wei H; Chen L; Demir Ö; Sandusky G; Sun E; Wang J; Mo J; Zeng L; Fishel M; Safa A; Amaro R; Korc M; Zhang ZY; Lu T
Oncotarget; 2017 Jun; 8(25):39963-39977. PubMed ID: 28591716
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening.
Wang Q; Xu J; Li Y; Huang J; Jiang Z; Wang Y; Liu L; Leung ELH; Yao X
Front Pharmacol; 2018; 9():173. PubMed ID: 29545752
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent quorum sensing in
Srinivasarao S; Nandikolla A; Nizalapur S; Yu TT; Pulya S; Ghosh B; Murugesan S; Kumar N; Chandra Sekhar KVG
RSC Adv; 2019 Sep; 9(50):29273-29292. PubMed ID: 35528444
[TBL] [Abstract][Full Text] [Related]
36. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
Shi L; Wu TT; Wang Z; Xue JY; Xu YG
Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
[TBL] [Abstract][Full Text] [Related]
37. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
[TBL] [Abstract][Full Text] [Related]
38. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
[TBL] [Abstract][Full Text] [Related]
39. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Anticancer Profile of New 4-(1
Abdel-Maksoud MS; Mohamed AAB; Hassan RM; Abdelgawad MA; Chilingaryan G; Selim S; Abdel-Bakky MS; Al-Sanea MM
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
